3-(2-amino-4-fluoro-1,3-benzothiazol-6-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(2-aminoquinolin-6-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-(2-hydroxyethylsulfonyl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[3-(4-hydroxypiperidin-1-yl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(1-oxo-2,3-dihydroisoindol-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(6-piperidin-4-yl-3-pyridinyl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide

C101H83F19N38O17S8 — CID 159206289

IUPAC3-(2-amino-4-fluoro-1,3-benzothiazol-6-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(2-aminoquinolin-6-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-(2-hydroxyethylsulfonyl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[3-(4-hydroxypiperidin-1-yl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(1-oxo-2,3-dihydroisoindol-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(6-piperidin-4-yl-3-pyridinyl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide
SMILESNS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc(C3CCNCC3)nc2)c1-c1nn[nH]n1.NS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc(S(=O)(=O)CCO)cc2)c1-c1nn[nH]n1.NS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc3c(c2)CNC3=O)c1-c1nn[nH]n1.NS(=O)(=O)c1c(C(F)(F)F)ccc(-c2cccc(N3CCC(O)CC3)c2)c1-c1nn[nH]n1.Nc1ccc2cc(-c3ccc(C(F)(F)F)c(S(N)(=O)=O)c3-c3nn[nH]n3)ccc2n1.Nc1nc2c(F)cc(-c3ccc(C(F)(F)F)c(S(N)(=O)=O)c3-c3nn[nH]n3)cc2s1
InChIInChI=1S/C19H19F3N6O3S.C18H18F3N7O2S.C17H12F3N7O2S.C16H11F3N6O3S.C16H14F3N5O5S2.C15H9F4N7O2S2/c20-19(21,22)15-5-4-14(16(17(15)32(23,30)31)18-24-26-27-25-18)11-2-1-3-12(10-11)28-8-6-13(29)7-9-28;19-18(20,21)13-3-2-12(15(16(13)31(22,29)30)17-25-27-28-26-17)11-1-4-14(24-9-11)10-5-7-23-8-6-10;18-17(19,20)11-4-3-10(8-1-5-12-9(7-8)2-6-13(21)23-12)14(15(11)30(22,28)29)16-24-26-27-25-16;17-16(18,19)11-4-3-9(7-1-2-10-8(5-7)6-21-15(10)26)12(13(11)29(20,27)28)14-22-24-25-23-14;17-16(18,19)12-6-5-11(9-1-3-10(4-2-9)30(26,27)8-7-25)13(14(12)31(20,28)29)15-21-23-24-22-15;16-8-3-5(4-9-11(8)22-14(20)29-9)6-1-2-7(15(17,18)19)12(30(21,27)28)10(6)13-23-25-26-24-13/h1-5,10,13,29H,6-9H2,(H2,23,30,31)(H,24,25,26,27);1-4,9-10,23H,5-8H2,(H2,22,29,30)(H,25,26,27,28);1-7H,(H2,21,23)(H2,22,28,29)(H,24,25,26,27);1-5H,6H2,(H,21,26)(H2,20,27,28)(H,22,23,24,25);1-6,25H,7-8H2,(H2,20,28,29)(H,21,22,23,24);1-4H,(H2,20,22)(H2,21,27,28)(H,23,24,25,26)
InChIKeyKPXVZJODKKGLKI-UHFFFAOYSA-N
MW2718.52 g/mol
LogP11.49
Rot. Bonds23

About 3-(2-amino-4-fluoro-1,3-benzothiazol-6-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(2-aminoquinolin-6-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-(2-hydroxyethylsulfonyl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[3-(4-hydroxypiperidin-1-yl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(1-oxo-2,3-dihydroisoindol-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(6-piperidin-4-yl-3-pyridinyl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide

3-(2-amino-4-fluoro-1,3-benzothiazol-6-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(2-aminoquinolin-6-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-(2-hydroxyethylsulfonyl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[3-(4-hydroxypiperidin-1-yl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(1-oxo-2,3-dihydroisoindol-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(6-piperidin-4-yl-3-pyridinyl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide (PubChem CID 159206289) has the molecular formula C101H83F19N38O17S8 and a molecular weight of 2718.52 g/mol. Its IUPAC name is 3-(2-amino-4-fluoro-1,3-benzothiazol-6-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(2-aminoquinolin-6-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-(2-hydroxyethylsulfonyl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[3-(4-hydroxypiperidin-1-yl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(1-oxo-2,3-dihydroisoindol-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(6-piperidin-4-yl-3-pyridinyl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide.

Molecular Properties

Compound Name3-(2-amino-4-fluoro-1,3-benzothiazol-6-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(2-aminoquinolin-6-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-(2-hydroxyethylsulfonyl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[3-(4-hydroxypiperidin-1-yl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(1-oxo-2,3-dihydroisoindol-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(6-piperidin-4-yl-3-pyridinyl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide
PubChem CID159206289
Molecular FormulaC101H83F19N38O17S8
Molecular Weight2718.52 g/mol
Exact Mass2716.43
IUPAC Name3-(2-amino-4-fluoro-1,3-benzothiazol-6-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(2-aminoquinolin-6-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-(2-hydroxyethylsulfonyl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[3-(4-hydroxypiperidin-1-yl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(1-oxo-2,3-dihydroisoindol-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(6-piperidin-4-yl-3-pyridinyl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide
SMILESNS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc(C3CCNCC3)nc2)c1-c1nn[nH]n1.NS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc(S(=O)(=O)CCO)cc2)c1-c1nn[nH]n1.NS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc3c(c2)CNC3=O)c1-c1nn[nH]n1.NS(=O)(=O)c1c(C(F)(F)F)ccc(-c2cccc(N3CCC(O)CC3)c2)c1-c1nn[nH]n1.Nc1ccc2cc(-c3ccc(C(F)(F)F)c(S(N)(=O)=O)c3-c3nn[nH]n3)ccc2n1.Nc1nc2c(F)cc(-c3ccc(C(F)(F)F)c(S(N)(=O)=O)c3-c3nn[nH]n3)cc2s1
InChIInChI=1S/C19H19F3N6O3S.C18H18F3N7O2S.C17H12F3N7O2S.C16H11F3N6O3S.C16H14F3N5O5S2.C15H9F4N7O2S2/c20-19(21,22)15-5-4-14(16(17(15)32(23,30)31)18-24-26-27-25-18)11-2-1-3-12(10-11)28-8-6-13(29)7-9-28;19-18(20,21)13-3-2-12(15(16(13)31(22,29)30)17-25-27-28-26-17)11-1-4-14(24-9-11)10-5-7-23-8-6-10;18-17(19,20)11-4-3-10(8-1-5-12-9(7-8)2-6-13(21)23-12)14(15(11)30(22,28)29)16-24-26-27-25-16;17-16(18,19)11-4-3-9(7-1-2-10-8(5-7)6-21-15(10)26)12(13(11)29(20,27)28)14-22-24-25-23-14;17-16(18,19)12-6-5-11(9-1-3-10(4-2-9)30(26,27)8-7-25)13(14(12)31(20,28)29)15-21-23-24-22-15;16-8-3-5(4-9-11(8)22-14(20)29-9)6-1-2-7(15(17,18)19)12(30(21,27)28)10(6)13-23-25-26-24-13/h1-5,10,13,29H,6-9H2,(H2,23,30,31)(H,24,25,26,27);1-4,9-10,23H,5-8H2,(H2,22,29,30)(H,25,26,27,28);1-7H,(H2,21,23)(H2,22,28,29)(H,24,25,26,27);1-5H,6H2,(H,21,26)(H2,20,27,28)(H,22,23,24,25);1-6,25H,7-8H2,(H2,20,28,29)(H,21,22,23,24);1-4H,(H2,20,22)(H2,21,27,28)(H,23,24,25,26)
InChIKeyKPXVZJODKKGLKI-UHFFFAOYSA-N
XLogP11.49
TPSA897.40 Ų
H-Bond Donors18
H-Bond Acceptors43
Rotatable Bonds23
Heavy Atoms183
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002718.52
LogP ≤ 511.49
H-Bond Donors ≤ 518
H-Bond Acceptors ≤ 1043

Analyze 3-(2-amino-4-fluoro-1,3-benzothiazol-6-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(2-aminoquinolin-6-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-(2-hydroxyethylsulfonyl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[3-(4-hydroxypiperidin-1-yl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(1-oxo-2,3-dihydroisoindol-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(6-piperidin-4-yl-3-pyridinyl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

3-(2-amino-1,3-benzothiazol-4-yl)-6-butyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-(2-amino-1,3-benzothiazol-4-yl)-6-(1-fluoropropyl)-2-(2H-tetrazol-5-yl)benzenesulfonamide;2-[4-(2-amino-1,3-benzothiazol-4-yl)-2-methylsulfonyl-3-(2H-tetrazol-5-yl)phenyl]ethanol;5-[4-cyclopropyl-3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]quinoline;2-[2-methylsulfonyl-4-quinolin-5-yl-3-(2H-tetrazol-5-yl)phenyl]ethanol;7-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-1H-indole-2-carboxamide
CID 158137813
N,N-dimethyl-3-propan-2-ylpyridin-2-amine;N,N-dimethyl-5-propan-2-ylpyridin-2-amine;2,6-dimethyl-3-propan-2-ylpyridine;1,6-dimethyl-5-propan-2-ylpyridin-2-one;2-ethyl-6-fluoro-3-propan-2-ylpyridine;2-ethyl-3-propan-2-ylpyridine;2-fluoro-6-methyl-3-propan-2-ylpyridine;2-methyl-7-propan-2-yl-1,3-benzothiazole;2-methyl-4-propan-2-yl-3H-isoindol-1-one;7-propan-2-yl-1,3-benzothiazol-2-amine;4-propan-2-yl-1,3-benzothiazole;5-propan-2-yl-1,3-benzothiazole;6-propan-2-yl-1,3-benzothiazole;7-propan-2-yl-1,3-benzothiazole;5-propan-2-yl-1-benzothiophene;5-propan-2-yl-2,3-dihydro-1H-indene;7-propan-2-yl-2,3-dihydroinden-1-one;4-propan-2-yl-2,3-dihydro-1H-indole;4-propan-2-yl-2,3-dihydro-1H-isoindole;5-propan-2-yl-2,3-dihydro-1H-isoindole;4-propan-2-yl-2,3-dihydroisoindol-1-one;3-propan-2-ylthieno[2,3-c]pyridine
CID 160642238

Frequently Asked Questions

What is the IUPAC name of 3-(2-amino-4-fluoro-1,3-benzothiazol-6-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(2-aminoquinolin-6-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-(2-hydroxyethylsulfonyl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[3-(4-hydroxypiperidin-1-yl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(1-oxo-2,3-dihydroisoindol-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(6-piperidin-4-yl-3-pyridinyl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide?
The IUPAC name of 3-(2-amino-4-fluoro-1,3-benzothiazol-6-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(2-aminoquinolin-6-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-(2-hydroxyethylsulfonyl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[3-(4-hydroxypiperidin-1-yl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(1-oxo-2,3-dihydroisoindol-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(6-piperidin-4-yl-3-pyridinyl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide (CID 159206289) is 3-(2-amino-4-fluoro-1,3-benzothiazol-6-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(2-aminoquinolin-6-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-(2-hydroxyethylsulfonyl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[3-(4-hydroxypiperidin-1-yl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(1-oxo-2,3-dihydroisoindol-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(6-piperidin-4-yl-3-pyridinyl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide.
What is the SMILES notation for 3-(2-amino-4-fluoro-1,3-benzothiazol-6-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(2-aminoquinolin-6-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-(2-hydroxyethylsulfonyl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[3-(4-hydroxypiperidin-1-yl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(1-oxo-2,3-dihydroisoindol-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(6-piperidin-4-yl-3-pyridinyl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide?
The canonical SMILES for 3-(2-amino-4-fluoro-1,3-benzothiazol-6-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(2-aminoquinolin-6-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-(2-hydroxyethylsulfonyl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[3-(4-hydroxypiperidin-1-yl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(1-oxo-2,3-dihydroisoindol-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(6-piperidin-4-yl-3-pyridinyl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide is NS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc(C3CCNCC3)nc2)c1-c1nn[nH]n1.NS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc(S(=O)(=O)CCO)cc2)c1-c1nn[nH]n1.NS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc3c(c2)CNC3=O)c1-c1nn[nH]n1.NS(=O)(=O)c1c(C(F)(F)F)ccc(-c2cccc(N3CCC(O)CC3)c2)c1-c1nn[nH]n1.Nc1ccc2cc(-c3ccc(C(F)(F)F)c(S(N)(=O)=O)c3-c3nn[nH]n3)ccc2n1.Nc1nc2c(F)cc(-c3ccc(C(F)(F)F)c(S(N)(=O)=O)c3-c3nn[nH]n3)cc2s1.
What is the InChIKey of 3-(2-amino-4-fluoro-1,3-benzothiazol-6-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(2-aminoquinolin-6-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-(2-hydroxyethylsulfonyl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[3-(4-hydroxypiperidin-1-yl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(1-oxo-2,3-dihydroisoindol-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(6-piperidin-4-yl-3-pyridinyl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide?
The InChIKey is KPXVZJODKKGLKI-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H19F3N6O3S.C18H18F3N7O2S.C17H12F3N7O2S.C16H11F3N6O3S.C16H14F3N5O5S2.C15H9F4N7O2S2/c20-19(21,22)15-5-4-14(16(17(15)32(23,30)31)18-24-26-27-25-18)11-2-1-3-12(10-11)28-8-6-13(29)7-9-28;19-18(20,21)13-3-2-12(15(16(13)31(22,29)30)17-25-27-28-26-17)11-1-4-14(24-9-11)10-5-7-23-8-6-10;18-17(19,20)11-4-3-10(8-1-5-12-9(7-8)2-6-13(21)23-12)14(15(11)30(22,28)29)16-24-26-27-25-16;17-16(18,19)11-4-3-9(7-1-2-10-8(5-7)6-21-15(10)26)12(13(11)29(20,27)28)14-22-24-25-23-14;17-16(18,19)12-6-5-11(9-1-3-10(4-2-9)30(26,27)8-7-25)13(14(12)31(20,28)29)15-21-23-24-22-15;16-8-3-5(4-9-11(8)22-14(20)29-9)6-1-2-7(15(17,18)19)12(30(21,27)28)10(6)13-23-25-26-24-13/h1-5,10,13,29H,6-9H2,(H2,23,30,31)(H,24,25,26,27);1-4,9-10,23H,5-8H2,(H2,22,29,30)(H,25,26,27,28);1-7H,(H2,21,23)(H2,22,28,29)(H,24,25,26,27);1-5H,6H2,(H,21,26)(H2,20,27,28)(H,22,23,24,25);1-6,25H,7-8H2,(H2,20,28,29)(H,21,22,23,24);1-4H,(H2,20,22)(H2,21,27,28)(H,23,24,25,26).
What are the key properties of 3-(2-amino-4-fluoro-1,3-benzothiazol-6-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(2-aminoquinolin-6-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-(2-hydroxyethylsulfonyl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[3-(4-hydroxypiperidin-1-yl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(1-oxo-2,3-dihydroisoindol-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(6-piperidin-4-yl-3-pyridinyl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide?
3-(2-amino-4-fluoro-1,3-benzothiazol-6-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(2-aminoquinolin-6-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-(2-hydroxyethylsulfonyl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[3-(4-hydroxypiperidin-1-yl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(1-oxo-2,3-dihydroisoindol-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(6-piperidin-4-yl-3-pyridinyl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide has a molecular weight of 2718.52 g/mol, XLogP of 11.49, 23 rotatable bonds, 18 hydrogen bond donors, and 43 hydrogen bond acceptors.
Where does this data come from?
All data for 3-(2-amino-4-fluoro-1,3-benzothiazol-6-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(2-aminoquinolin-6-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-(2-hydroxyethylsulfonyl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[3-(4-hydroxypiperidin-1-yl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(1-oxo-2,3-dihydroisoindol-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(6-piperidin-4-yl-3-pyridinyl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide is sourced from PubChem (CID 159206289), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).